[go: up one dir, main page]

WO2000040217B1 - Composition topique comprenant des aldosamines de n-acetyle ou des acides amines de n-acetyle - Google Patents

Composition topique comprenant des aldosamines de n-acetyle ou des acides amines de n-acetyle

Info

Publication number
WO2000040217B1
WO2000040217B1 PCT/US2000/000330 US0000330W WO0040217B1 WO 2000040217 B1 WO2000040217 B1 WO 2000040217B1 US 0000330 W US0000330 W US 0000330W WO 0040217 B1 WO0040217 B1 WO 0040217B1
Authority
WO
WIPO (PCT)
Prior art keywords
acetyl
acid
group
skin
aceryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2000/000330
Other languages
English (en)
Other versions
WO2000040217A1 (fr
Inventor
Ruey J Yu
Scott Eugene J Van
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
YuGenic LP
Original Assignee
YuGenic LP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22852222&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=WO2000040217(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority to EP10006974.9A priority Critical patent/EP2311452B2/fr
Priority to AU24080/00A priority patent/AU775209B2/en
Priority to EP00902347A priority patent/EP1143925B2/fr
Priority to CA2358457A priority patent/CA2358457C/fr
Priority to MXPA01006917A priority patent/MXPA01006917A/es
Application filed by YuGenic LP filed Critical YuGenic LP
Priority to BR0007430-6A priority patent/BR0007430A/pt
Priority to DE60022162T priority patent/DE60022162T3/de
Priority to JP2000591974A priority patent/JP2002534369A/ja
Publication of WO2000040217A1 publication Critical patent/WO2000040217A1/fr
Publication of WO2000040217B1 publication Critical patent/WO2000040217B1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/447—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/008—Preparations for oily skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention concerne des composés comprenant N-acétyle-aldosamines, des acides N-acétylaminés, et des composés de N-acétyle apparentés utiles pour atténuer ou améliorer divers états cosmétiques et divers troubles dermatologiques, notamment les modifications ou altérations de la peau, des ongles et des cheveux liées au vieillissement intrinsèque et/ou extrinsèque, de même que les modifications ou altérations causées par des facteurs extrinsèques. Les N-acétyle-aldosamines, les acides N-acétylaminés et une composition N-acétyle apparentés peuvent aussi comprendre un cosmétique, un agent pharmaceutique ou un autre agent topique permettant de renforcer ou de créer un effet de synergie.
PCT/US2000/000330 1999-01-08 2000-01-07 Composition topique comprenant des aldosamines de n-acetyle ou des acides amines de n-acetyle Ceased WO2000040217A1 (fr)

Priority Applications (8)

Application Number Priority Date Filing Date Title
JP2000591974A JP2002534369A (ja) 1999-01-08 2000-01-07 Ｎ−アセチルアルドースアミン又はｎ−アセチルアミノ酸からなる局所療法用組成物
AU24080/00A AU775209B2 (en) 1999-01-08 2000-01-07 Topical composition comprising N-acetylaldosamines or N-acetylamino acids
EP00902347A EP1143925B2 (fr) 1999-01-08 2000-01-07 Composition topique comprenant de la n-acetyl glucosamine
CA2358457A CA2358457C (fr) 1999-01-08 2000-01-07 Composition topique comprenant des aldosamines de n-acetyle ou des acides amines de n-acetyle
MXPA01006917A MXPA01006917A (es) 1999-01-08 2000-01-07 Composicion topica que comprende n-acetilaldosaminas o acidos n-acetilaminos.
EP10006974.9A EP2311452B2 (fr) 1999-01-08 2000-01-07 Composition topique contenant du N-acétylglucosamine
BR0007430-6A BR0007430A (pt) 1999-01-08 2000-01-07 Composição tópica compreendendo n-acetilaminoácidos ou n-acetilaldosaminas
DE60022162T DE60022162T3 (de) 1999-01-08 2000-01-07 Topische zusammensetzung mit n-acetylglukosamin

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/227,213 1999-01-08
US09/227,213 US6159485A (en) 1999-01-08 1999-01-08 N-acetyl aldosamines, n-acetylamino acids and related n-acetyl compounds and their topical use

Publications (2)

Publication Number Publication Date
WO2000040217A1 WO2000040217A1 (fr) 2000-07-13
WO2000040217B1 true WO2000040217B1 (fr) 2000-10-05

Family

ID=22852222

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/000330 Ceased WO2000040217A1 (fr) 1999-01-08 2000-01-07 Composition topique comprenant des aldosamines de n-acetyle ou des acides amines de n-acetyle

Country Status (11)

Country Link
US (7) US6159485A (fr)
EP (5) EP2311452B2 (fr)
JP (2) JP2002534369A (fr)
CN (1) CN1336817A (fr)
AU (1) AU775209B2 (fr)
BR (1) BR0007430A (fr)
CA (3) CA2778317C (fr)
DE (2) DE60041934D1 (fr)
ES (3) ES2325160T3 (fr)
MX (1) MXPA01006917A (fr)
WO (1) WO2000040217A1 (fr)

Families Citing this family (197)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2761600B1 (fr) 1998-06-19 2000-03-31 Oreal Composition moussante pour le lavage et le traitement des cheveux et/ou du cuir chevelu a base d'un principe actif, d'un tensioactif anionique, d'un tensioactif amphotere et d'un agent propenetrant
US6808716B2 (en) * 1999-01-08 2004-10-26 Ruey J. Yu N-acetylamino acids, related N-acetyl compounds and their topical use
US6159485A (en) 1999-01-08 2000-12-12 Yugenic Limited Partnership N-acetyl aldosamines, n-acetylamino acids and related n-acetyl compounds and their topical use
US6413525B1 (en) 1999-05-06 2002-07-02 Color Access, Inc. Methods of exfoliation using N-acetyl glucosamine
FR2794974B1 (fr) * 1999-06-16 2001-08-17 Exsymol Sa Composition cosmetique pour l'amincissement a base de l-arginine, d'un analogue de l-arginine ou d'un de leurs derives, applicable par voie topique
US6242491B1 (en) 1999-06-25 2001-06-05 Rima Kaddurah-Daouk Use of creatine or creatine compounds for skin preservation
US7083781B2 (en) 1999-08-19 2006-08-01 Lavipharm S.A. Film forming polymers, methods of use, and devices and applications thereof
EP1304323A4 (fr) * 2000-07-19 2005-01-12 Kyowa Hakko Kogyo Kk Agents de prevention ou de traitement de la dermite atopique
JP2002128651A (ja) * 2000-10-25 2002-05-09 Kose Corp 光老化抑制剤およびそれを含有することを特徴とする皮膚外用剤
EP1343492B1 (fr) * 2000-11-22 2006-02-01 Rxkinetix, Inc. Traitement de mucosite
JP2002193782A (ja) * 2000-12-22 2002-07-10 Shiyuu Uemura Keshohin:Kk 皮膚化粧料
ATE354363T1 (de) * 2001-01-05 2007-03-15 Kyowa Hakko Kogyo Kk Kombination von drei substanzen zur vorbeugung und behandlung von arthritis
WO2002062341A1 (fr) * 2001-02-07 2002-08-15 University Of Florida Procede et composition permettant de reguler la pousse des cheveux
CN1168453C (zh) * 2001-02-28 2004-09-29 中国人民解放军第三军医大学 N-乙酰-d-氨基葡萄糖在制备防治晕动病药物中的应用
NL1017487C2 (nl) * 2001-03-02 2002-09-06 Caral B V I O Preparaat met polydimethylsiloxaan voor aandoeningen van nagels, kraakbeen, botten, gewrichten, spieren en pezen.
US20020182237A1 (en) * 2001-03-22 2002-12-05 The Procter & Gamble Company Skin care compositions containing a sugar amine
DE10114561A1 (de) † 2001-03-24 2002-09-26 Wella Ag Verwendung von Mitteln enthaltend Kreatin, Kreatin und/oder deren Derivaten zur Verstärkung und Strukturverbesserung von keratinischen Fasern
AU2002309092A1 (en) * 2001-03-30 2002-10-15 L'oreal Compositions comprising at least one saccharide type compound and their use for the protection and/or repair of hair
WO2002096374A2 (fr) 2001-05-31 2002-12-05 Upsher-Smith Laboratories, Inc. Préparations et procédés dermatologiques
JP5000049B2 (ja) * 2001-08-27 2012-08-15 株式会社ファンケル 老化防止剤
EP1297830A1 (fr) * 2001-09-28 2003-04-02 Flamma Fabbrica Lombarda Ammino Acidi S.p.a. L'utilisation des acides aminés alpha ou bèta, leurs esters, ou de dipeptides de ces acides aminés avec des dérivés d'histidine, dans la prévention ou le traitement de lésions de la peau causées par l'ozone atmosphérique
US20050209131A1 (en) * 2001-11-16 2005-09-22 Singleton Laura C Composition containing peptides complexed with a copper ion
WO2003045494A2 (fr) * 2001-11-17 2003-06-05 Martinez-Colon Maria Therapies faisant appel a l'imiquimod
US6824786B2 (en) * 2001-11-27 2004-11-30 Ruey J. Yu Compositions comprising phenyl-glycine derivatives
FR2834213B1 (fr) * 2001-12-27 2004-06-04 Pharmascience Lab Composition cosmetique ou pharmaceutique comprenant au moins une alcanolamide pour inhiber la migration des cellules de langerhans, et ses utilisations
MC200053A1 (fr) * 2002-01-04 2002-07-29 A M Exsymol S Utilisation de derives de la L-arginine comme agents photoprotecteurs et optimisant la reponse melanique dans des compositions cosmetiques
US6869598B2 (en) * 2002-03-22 2005-03-22 Unilever Home & Personal Care Usa Division Of Conopco, Inc. Stabilization of sunscreens in cosmetic compositions
US20040033963A1 (en) * 2002-04-10 2004-02-19 Yu Ruey J. Urea composition
IL152397A (en) * 2002-10-21 2009-02-11 Hadasit Med Res Service Compositions and compounds for the treatment of hyperglycemia
US7374772B2 (en) * 2002-11-07 2008-05-20 Bommarito Alexander A Topical antifungal treatment
US20050019356A1 (en) * 2003-07-25 2005-01-27 The Procter & Gamble Company Regulation of mammalian keratinous tissue using N-acyl amino acid compositions
US20080076720A1 (en) * 2003-03-04 2008-03-27 Sancai Xie Personal care compositions having kinetin or zeatin
US20040214215A1 (en) * 2003-03-07 2004-10-28 Yu Ruey J. Bioavailability and improved delivery of alkaline pharmaceutical drugs
US20060063827A1 (en) * 2004-09-23 2006-03-23 Yu Ruey J Systemic administration of therapeutic amino acids and N-acetylamino acids
US20040220264A1 (en) * 2003-03-17 2004-11-04 Yu Ruey J Bioavailability and improved delivery of acidic pharmaceutical drugs
DE10316666B4 (de) * 2003-04-10 2015-04-09 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen mit einer Kombination von Kreatinin mit Kreatin und Coenzym Q10
WO2005030083A2 (fr) * 2003-09-25 2005-04-07 Dmi Biosciences Inc. Methodes et produits faisant intervenir de l'acide n-acyl-l-aspartique
US7960350B2 (en) * 2003-10-24 2011-06-14 Ader Enterprises, Inc. Composition and method for the treatment of eye disease
CN100475184C (zh) * 2003-10-31 2009-04-08 宝洁公司 包含脱氢乙酸和护肤活性物质的护肤组合物
ES2998457T3 (en) * 2003-11-21 2025-02-20 Nestle Sa Food composition comprising glucosamine
JP5241058B2 (ja) * 2003-11-27 2013-07-17 株式会社 資生堂 不全角化抑制剤及び毛穴縮小剤
WO2005051340A1 (fr) 2003-11-27 2005-06-09 Shiseido Company, Ltd. Inhibiteurs de parakeratose et composition externe cutanee
WO2005055947A2 (fr) * 2003-12-08 2005-06-23 Yu Ruey J Optimisation d'organes et de sites cutaneo-muqueux ou cutanes au moyen de compositions topiques
DE102004010717A1 (de) * 2004-03-03 2005-09-22 Beiersdorf Ag Reinigungszubereitung mit Kreatin
US20050196418A1 (en) * 2004-03-04 2005-09-08 Yu Ruey J. Bioavailability and improved delivery of alkaline pharmaceutical drugs
JP4496375B2 (ja) * 2004-05-21 2010-07-07 国立大学法人鳥取大学 創傷の治療又は処置のための薬剤
US8338648B2 (en) 2004-06-12 2012-12-25 Signum Biosciences, Inc. Topical compositions and methods for epithelial-related conditions
US7754875B1 (en) 2004-09-17 2010-07-13 Jfc Technologies, Llc Halide-free glucosamine base-organic acid salt compositions
WO2006054792A1 (fr) * 2004-11-19 2006-05-26 Shiseido Company, Ltd. Agent améliorant l’élasticité et la résistance des cheveux, et préparation cosmétique pour cheveux
US20060127342A1 (en) * 2004-12-09 2006-06-15 Georgia Levis Taurine-based compositions, therapeutic methods, and assays
US20060147504A1 (en) * 2004-12-30 2006-07-06 Bobby Corry Feminine anti-itch cloth
US20060166901A1 (en) * 2005-01-03 2006-07-27 Yu Ruey J Compositions comprising O-acetylsalicyl derivatives of aminocarbohydrates and amino acids
FR2880802B1 (fr) * 2005-01-14 2008-12-19 Sederma Soc Par Actions Simpli Composition cosmetique ou dermopharmaceutique contenant un extrait d'euglene
US8252308B2 (en) * 2005-01-27 2012-08-28 C.B. Fleet Company Inc. Feminine anti-itch gel
US20060211754A1 (en) * 2005-03-16 2006-09-21 Yu Ruey J Compositions comprising N-propanoyl derivatives of amino acids, aminocarbohydrates and derivatives thereof
US9616011B2 (en) 2005-04-27 2017-04-11 The Procter & Gamble Company Personal care compositions
US20080095732A1 (en) * 2005-04-27 2008-04-24 Rosemarie Osborne Personal care compositions
US20070020220A1 (en) * 2005-04-27 2007-01-25 Procter & Gamble Personal care compositions
JP4865251B2 (ja) * 2005-05-09 2012-02-01 株式会社 資生堂 不全角化抑制剤、毛穴縮小剤及び皮膚外用組成物
FR2885522B1 (fr) * 2005-05-13 2020-01-10 Sederma Composition cosmetique ou dermopharmaceutique contenant de la teprenone
US20070020221A1 (en) * 2005-05-17 2007-01-25 Bissett Donald L Regulation of mammalian keratinous tissue using personal care compositions comprising cetyl pyridinium chloride
US20060263321A1 (en) * 2005-05-17 2006-11-23 The Procter & Gamble Company Regulation of mammalian keratinous tissue using personal care compositions comprising diethylhexyl syringylidene malonate
US20060263309A1 (en) * 2005-05-17 2006-11-23 Bissett Donald L Regulation of mammalian keratinous tissue using personal care compositions comprising tetrahydrocurcumin
JP5014592B2 (ja) * 2005-05-25 2012-08-29 株式会社 資生堂 不全角化抑制剤、毛穴縮小剤，肌荒れ防止・改善剤
WO2007001904A2 (fr) * 2005-06-21 2007-01-04 The Procter & Gamble Company Compositions cosmetiques contenant des alpha-glucanes et/ou des beta-glucanes
CN101227885A (zh) * 2005-07-26 2008-07-23 株式会社资生堂 皱纹防止·改善剂
FR2890310B1 (fr) * 2005-09-06 2009-04-03 Sederma Soc Par Actions Simpli Utilisation des protoberberines comme agents regulant l'activite de l'unite pilosebacee
US20100035881A1 (en) * 2005-09-22 2010-02-11 Shiseido Company, Ltd. Wrinkle-improving agent
WO2007041548A2 (fr) * 2005-09-30 2007-04-12 The Procter & Gamble Company Regulation d'un tissu keratinise d'un mammifere par des substances actives pour les soins de la peau
AU2006320538B2 (en) * 2005-11-30 2013-07-04 Endo Pharmaceuticals Inc. Treatment of xerostomia with a sulfur-containing antioxidant
US20070196292A1 (en) * 2005-11-30 2007-08-23 Robinson Larry R Personal care composition comprising dehydroacetate salts
US20070196296A1 (en) * 2005-12-13 2007-08-23 Rosemarie Osborne Personal care compositions
WO2007070523A2 (fr) * 2005-12-13 2007-06-21 The Procter & Gamble Company Compositions pour soins personnels
JP2007197371A (ja) * 2006-01-26 2007-08-09 Yaizu Suisankagaku Industry Co Ltd 美肌促進剤及び美容健康食品
WO2007093839A1 (fr) * 2006-02-16 2007-08-23 Sederma Nouveaux polypeptides kxk et leurs applications
US20080031833A1 (en) * 2006-03-13 2008-02-07 Oblong John E Combined energy and topical composition application for regulating the condition of mammalian skin
EP2001558A2 (fr) * 2006-03-21 2008-12-17 Henkel AG & Co. KGaA Décoloration réductive
EP2283899B1 (fr) * 2006-03-21 2017-07-19 Henkel AG & Co. KGaA Décoloration réductive
FR2900573B1 (fr) * 2006-05-05 2014-05-16 Sederma Sa Nouvelles compositions cosmetiques renfermant au moins un peptide contenant au moins un cycle aromatique bloque
FR2901134B1 (fr) * 2006-05-19 2008-10-03 Galderma Sa Utilisation d'une composition comprenant une association d'hydroquinone, d'acetonide de fluocinolone, et de tretinoine, destinee au traitement des signes cutanes du photovieillissement
EA016043B1 (ru) 2006-07-25 2012-01-30 Замбон С.П.А Косметические или дерматологические препараты, содержащие n-ацетилцистеин
FR2904549B1 (fr) * 2006-08-03 2012-12-14 Sederma Sa Composition comprenant de la sarsasapogenine
WO2008101310A1 (fr) * 2007-02-20 2008-08-28 Multi Formulations Ltd. Créatine-acides gras
US7319157B1 (en) 2007-02-20 2008-01-15 Multi Formulations Ltd. Creatine-fatty acids
EP2117536A2 (fr) 2007-02-22 2009-11-18 Beiersdorf AG Applications cosmétiques et pharmaceutiques d'acides aminés n-acylés, et composés structurellement apparentés
US8469621B2 (en) * 2007-02-27 2013-06-25 The Procter & Gamble Company Personal care product having a solid personal care composition within a structure maintaining dispenser
CN101621987B (zh) * 2007-02-28 2013-08-21 宝洁公司 包含孟加拉榕树植物提取物的个人护理组合物
US20090017080A1 (en) * 2007-03-15 2009-01-15 Paul Robert Tanner Personal care kit having skin care compositions with a readily perceptible difference
JP2009073806A (ja) * 2007-08-27 2009-04-09 Iriya Cosmetics Co Ltd インスリン様成長因子−１分泌促進剤
US8466187B2 (en) 2007-09-18 2013-06-18 Thermolife International, Llc Amino acid compositions
US9119866B2 (en) 2008-04-08 2015-09-01 Huiru Wang Glycan-based drugs, therapies and biomarkers
US8546369B2 (en) 2008-05-30 2013-10-01 Northern Innovations Holding Corp. Salts of creatine imino sugar amides
FR2935378B1 (fr) * 2008-08-29 2015-03-27 Seppic Sa Utiisation de n-acyl aminoacides comme principes actifs cosmetiques et pharmaceutiques, capables de reduire l'etat inflammatoire des fibroblastes replicatifs senescents issus du derme humain adulte; compositions cosmetiques anti-age
FR2939799B1 (fr) 2008-12-11 2011-03-11 Sederma Sa Composition cosmetique comprenant des oligoglucuronanes acetyles.
FR2941232B1 (fr) 2009-01-16 2014-08-08 Sederma Sa Nouveaux peptides, compositions les comprenant et utilisations cosmetiques et dermo-pharmaceutiques.
EP2382231A2 (fr) 2009-01-16 2011-11-02 Sederma Nouveaux composés, notamment des peptides, compositions comprenant ces derniers et leurs utilisations dans les domaines cosmétique et dermopharmaceutique
FR2941231B1 (fr) 2009-01-16 2016-04-01 Sederma Sa Nouveaux peptides, compositions les comprenant et utilisations cosmetiques et dermo-pharmaceutiques.
US9676696B2 (en) 2009-01-29 2017-06-13 The Procter & Gamble Company Regulation of mammalian keratinous tissue using skin and/or hair care actives
FR2944435B1 (fr) 2009-04-17 2011-05-27 Sederma Sa Composition cosmetique comprenant de l'oridonine
FR2945939B1 (fr) 2009-05-26 2011-07-15 Sederma Sa Utilisation cosmetique du dipeptide tyr-arg pour lutter contre le relachement cutane.
JP5564205B2 (ja) * 2009-06-05 2014-07-30 焼津水産化学工業株式会社 皮膚掻痒症改善剤
US20100322983A1 (en) * 2009-06-22 2010-12-23 Susan Adair Griffiths-Brophy Personal-Care Composition
EP3871671A3 (fr) 2009-07-29 2022-03-09 Olsen, Elise Antagonistes du recepteur fp pour inhiber la pousse des cheveux
US20110039928A1 (en) * 2009-08-13 2011-02-17 Golini Jeffrey M Cetylated fatty acid and alkali buffered creatine anti-inflammatory composition
BR112012024963A2 (pt) 2010-04-01 2016-07-12 Procter & Gamble organossilicones
US9186642B2 (en) 2010-04-28 2015-11-17 The Procter & Gamble Company Delivery particle
US20110269657A1 (en) 2010-04-28 2011-11-03 Jiten Odhavji Dihora Delivery particles
US9993793B2 (en) 2010-04-28 2018-06-12 The Procter & Gamble Company Delivery particles
US20120172281A1 (en) 2010-07-15 2012-07-05 Jeffrey John Scheibel Detergent compositions comprising microbially produced fatty alcohols and derivatives thereof
US9737472B2 (en) 2010-08-09 2017-08-22 Allele Biotechnology & Pharmaceuticals, Inc. Light-absorbing compositions and methods of use
US9205284B2 (en) 2010-08-09 2015-12-08 Allele Biotechnology & Pharmaceuticals, Inc. Light-absorbing compositions and methods of use
US10842728B2 (en) 2010-08-09 2020-11-24 Allele Biotechnology & Pharmaceuticals, Inc. Light-absorbing compositions and methods of use
WO2012026639A1 (fr) * 2010-08-27 2012-03-01 (주)네오팜 Nouveau composé accélérant la sécrétion de peptide anti-microbien d'origine humaine, procédé de préparation associé et composition contenant ce composé comme principe actif
CN104257515B (zh) * 2010-10-22 2017-05-03 新钰生技股份有限公司 具有抑制黑色素生成的甘胺酸衍生物及使用其的美白组成物
IT1403257B1 (it) * 2010-12-06 2013-10-17 Intercos Italiana Composizioni cosmetiche contenenti composti con azione anti-glicazione, da usare per prevenire e rallentare il processo di invecchiamento cutaneo
KR101298575B1 (ko) * 2011-02-15 2013-08-22 대상 주식회사 Ｎ-아세틸-ｌ-글루타민을 유효성분으로 포함하는 화장료 조성물
EP2694017B1 (fr) 2011-04-07 2019-05-22 The Procter and Gamble Company Compositions d'hygiène personnelle à dépôt accru de microcapsules de polyacrylate
EP2694016B2 (fr) 2011-04-07 2025-03-19 The Procter & Gamble Company Compositions de shampooing à dépôt accru de microcapsules de polyacrylate
CN103458871B (zh) 2011-04-07 2015-05-13 宝洁公司 具有增强的聚丙烯酸酯微胶囊的沉积的调理剂组合物
AU2012242565B2 (en) * 2011-04-13 2017-05-11 Thermolife International, Llc N-Acetyl Beta Alanine methods of use
JP2014524900A (ja) 2011-06-13 2014-09-25 ザ プロクター アンド ギャンブル カンパニー ｐＨ調整可能なゲル化剤を含むパーソナルケア組成物及び使用方法
CN103930167A (zh) 2011-06-13 2014-07-16 宝洁公司 包含二酰氨基胶凝剂的个人护理组合物和使用方法
US9675531B2 (en) 2011-06-20 2017-06-13 The Procter & Gamble Company Personal care compositions comprising shaped abrasive particles
JP5702248B2 (ja) * 2011-07-28 2015-04-15 三菱製紙株式会社 ナノファイバー、ナノファイバーの形成方法およびナノファイバー集合体の形成方法
JP5254417B2 (ja) * 2011-10-07 2013-08-07 株式会社 資生堂 不全角化抑制剤、毛穴縮小剤及び肌荒れ防止・改善剤
FI3777876T3 (fi) 2011-10-28 2023-10-18 Neostrata Company Inc N-asyylidipeptidijohdannaisia ja niiden käyttöjä
EP2729220B1 (fr) * 2011-12-20 2015-11-04 Oriflame Research and Development Ltd. Composes avec l'activité contre le vieillissement
CA2863568A1 (fr) 2012-02-14 2013-08-22 The Procter & Gamble Company Utilisation topique d'un agent prebiotique commensal dermique et compositions le contenant
MX2014011153A (es) 2012-03-19 2014-12-10 Procter & Gamble Polimeros superabsorbentes y elastomero de silicona para usar en composiciones para el cuidado del cabello.
US20130243834A1 (en) 2012-03-19 2013-09-19 The Procter & Gamble Company Cross linked silicone copolmyer networks in a thickened aqueous phase
US9549891B2 (en) 2012-03-19 2017-01-24 The Procter & Gamble Company Superabsorbent polymers and sunscreen actives for use in skin care compositions
US9271912B2 (en) 2012-06-13 2016-03-01 The Procter & Gamble Company Personal care compositions comprising a pH tuneable gellant and methods of using
US9259343B2 (en) 2012-07-06 2016-02-16 Newman Technologies LLC Device for mitigating plantar fasciitis
FR2996128B1 (fr) * 2012-09-28 2015-01-02 Inneov Lab Utilisation d'une association de taurine ou un de ses derives, et d'extrait de raisins pour ameliorer la qualite des ongles.
GB201220354D0 (en) * 2012-11-12 2012-12-26 Medpharm Ltd Dermal compositions
US20140178314A1 (en) 2012-12-19 2014-06-26 The Procter & Gamble Company Compositions and/or articles with improved solubility of a solid active
US8901122B2 (en) 2012-12-20 2014-12-02 Avon Products, Inc. Collagen stimulators and their use in the treatment of skin
US9445981B2 (en) * 2012-12-20 2016-09-20 Avon Products, Inc PLOD-2 stimulators and their use in the treatment of skin
US8865700B2 (en) 2012-12-20 2014-10-21 Avon Products, Inc. Collagen stimulators and their use in the treatment of skin
US9511144B2 (en) 2013-03-14 2016-12-06 The Proctor & Gamble Company Cosmetic compositions and methods providing enhanced penetration of skin care actives
US20140314697A1 (en) * 2013-04-18 2014-10-23 Corum Inc. Method for Inhibiting Inflammation and Reducing Melanophilin Expression with Glycine Derivatives And the Composition Thereof
WO2014182993A2 (fr) 2013-05-10 2014-11-13 The Procter & Gamble Company Différenciation de produit à base d'émulsion modulaire
JP6186076B2 (ja) 2013-05-10 2017-08-23 ザ プロクター アンド ギャンブル カンパニー 標準エマルジョン系生成物の差別化
JP2016523692A (ja) 2013-05-10 2016-08-12 ザ プロクター アンド ギャンブル カンパニー 標準エマルジョン系生成物の差別化
WO2015099755A1 (fr) * 2013-12-27 2015-07-02 Colgate-Palmolive Company Méthodes de soins buccaux prébiotiques utilisant un saccharide
US20150209468A1 (en) 2014-01-24 2015-07-30 The Procter & Gamble Company Hygiene article containing microorganism
MX2016013894A (es) * 2014-04-24 2017-02-02 Procter & Gamble Composicion para el cuidado del cuero cabelludo.
MA54716A (fr) 2014-10-23 2021-11-17 Amgen Inc Réduction de la viscosité de formulations pharmaceutiques
WO2016077817A1 (fr) 2014-11-14 2016-05-19 The General Hospital Corporation Procédés et compositions pour augmenter la pigmentation de la peau
MX368900B (es) * 2014-12-04 2019-10-21 Professional Dietetics Spa Composicion a base de aminoacidos para recuperacion de fibroelastina en tejidos conectivos dermicos.
EP3250196A4 (fr) * 2015-01-27 2018-09-26 Florengale, LLC Composition topique de cicatrisation
JP6935169B2 (ja) * 2015-06-01 2021-09-15 株式会社コーセー ラメラ構造改善剤
US20160354507A1 (en) 2015-06-07 2016-12-08 The Procter & Gamble Company Article of commerce containing absorbent article
EP3313534A1 (fr) 2015-06-29 2018-05-02 The Procter and Gamble Company Polymères superabsorbants et poudres d'amidon utilisables dans des compositions de soins de la peau
US20170020750A1 (en) 2015-07-23 2017-01-26 The Procter & Gamble Company Patch containing microorganism
WO2017017585A1 (fr) * 2015-07-26 2017-02-02 Mohan M Alapati Composé, composition et utilisations associées
JP6346596B2 (ja) * 2015-08-31 2018-06-20 株式会社ミルボン 毛髪変形用第１剤、及び毛髪変形処理方法
WO2017074982A1 (fr) 2015-10-30 2017-05-04 Patagonia Pharmaceuticals, Llc Formulations d'isotrétinoïne, leurs utilisations et méthodes associées
JP6159382B2 (ja) * 2015-12-24 2017-07-05 花王株式会社 経口紫外線抵抗性向上剤
US10632736B2 (en) 2016-02-05 2020-04-28 The Procter & Gamble Company Systems and methods of applying compositions to webs
EP3426212B1 (fr) 2016-03-11 2020-10-21 The Procter and Gamble Company Bandes non tissées texturées avec des compositions
US20180071151A1 (en) 2016-09-09 2018-03-15 The Procter & Gamble Company Systems And Methods Of Applying Compositions To Webs And Webs Thereof
US10543240B2 (en) 2016-12-12 2020-01-28 Johnson & Johnson Consumer Inc. Topical composition containing glycerin and yeast extract
WO2018146051A1 (fr) * 2017-02-13 2018-08-16 Unilever Plc Procédé de renforcement de cheveux traités par oxydation
EP3579926B1 (fr) * 2017-02-13 2020-12-09 Unilever PLC Procédé de renforcement de cheveux
JP7377596B2 (ja) 2017-02-22 2023-11-10 アムジエン・インコーポレーテツド 低粘度、高濃度エボロクマブ製剤及びそれらの製造方法
EP3661600A4 (fr) 2017-10-23 2021-08-11 Epitracker, Inc. Analogues d'acides gras et leur utilisation dans le traitement des états liés au syndrome métabolique
KR102139678B1 (ko) * 2017-11-24 2020-07-31 전북대학교 산학협력단 N-아세틸 또는 n-아실 아미노산을 포함하는 아토피 또는 가려움증 치료용 조성물
WO2019103506A2 (fr) * 2017-11-24 2019-05-31 전북대학교 산학협력단 Composition pour traiter l'atopie ou le prurit comprenant un n-acétyle ou n-acyle associé à un acide aminé
JP7354143B2 (ja) * 2018-05-10 2023-10-02 ユニリーバー・アイピー・ホールディングス・ベスローテン・ヴェンノーツハップ 酸化処理した毛髪の修復方法
AU2019274431B2 (en) 2018-05-23 2025-03-13 Epitracker, Inc. Compositions and methods for diagnosis and treatment of conditions related to the quality of aging and longevity
JP7048051B2 (ja) * 2018-07-11 2022-04-05 正徳 染井 痒みを軽減するアトピー性皮膚炎治療剤
US11166997B2 (en) 2018-07-27 2021-11-09 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
JP2021532121A (ja) 2018-07-27 2021-11-25 ジョンソン・アンド・ジョンソン・サージカル・ビジョン・インコーポレイテッド 眼を治療するための組成物及び方法
WO2020021481A1 (fr) 2018-07-27 2020-01-30 Johnson & Johnson Vision Care, Inc. Compositions et méthodes de traitement de l'œil
US11110051B2 (en) 2018-08-30 2021-09-07 Johnson & Johnson Consumer Inc. Topical compositions comprising Pichia anomala and n-acetyl glucosamine
US11045416B2 (en) 2018-08-30 2021-06-29 Johnson & Johnson Consumer Inc. Topical compositions comprising Pichia anomala and retinol
CN110870860A (zh) * 2018-08-31 2020-03-10 成都夸常奥普医疗科技有限公司 包含氨基酸类营养素和常规无效化合物的药物组合物及其应用
CN110870869A (zh) * 2018-08-31 2020-03-10 成都夸常奥普医疗科技有限公司 包含糖类营养素和常规无效化合物的药物组合物及其应用
CN110870914A (zh) * 2018-08-31 2020-03-10 成都夸常奥普医疗科技有限公司 氨基酸类营养素的应用以及包含它的药物组合物
US11767314B2 (en) 2018-11-02 2023-09-26 Conopco, Inc. Bioenergetic nicotinic acid glycerol esters, compositions and methods of using same
EP3908374A4 (fr) 2019-01-09 2022-12-28 Epitracker, Inc. Compositions et méthodes pour le diagnostic et le traitement de maladies neurodégénératives
WO2020154173A1 (fr) * 2019-01-23 2020-07-30 Epitracker, Inc. Compositions et méthodes pour le diagnostic et le traitement d'affections liées à la longévité et à la qualité du vieillissement
JP7404382B2 (ja) 2019-03-04 2023-12-25 エピトラッカー インコーポレイテッド 脂肪酸アナログ、ならびに認知機能障害、行動症状および慢性疼痛の処置におけるそれらの使用
EP3996664B1 (fr) 2019-07-12 2024-08-21 Unilever Global IP Limited Stabilisation de composés de résorcinol dans des compositions cosmétiques
US20220362127A1 (en) 2019-07-12 2022-11-17 Conopco, Inc., D/B/A Unilever Bioenergetic combinations and methods of using same
US11969451B2 (en) 2019-11-19 2024-04-30 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
MX2023004232A (es) 2020-10-16 2023-04-21 Procter & Gamble Composiciones de productos de consumo con al menos dos poblaciones de encapsulados.
MX2023004231A (es) 2020-10-16 2023-04-21 Procter & Gamble Composiciones de producto de consumo que comprenden una poblacion de encapsulados.
US12486478B2 (en) 2020-10-16 2025-12-02 The Procter & Gamble Company Consumer products comprising delivery particles with high core:wall ratios
WO2022104157A1 (fr) 2020-11-12 2022-05-19 Thermolife International, Llc Méthodes pour accroître la saturation en oxygène du sang
US11865139B2 (en) 2020-11-12 2024-01-09 Thermolife International, Llc Method of treating migraines and headaches
IL315206A (en) 2021-02-11 2024-10-01 Thermolife Int Llc A method of administering nitric oxide gas
US20220323388A1 (en) 2021-04-01 2022-10-13 Yu Ruey J Creatine, its derivatives, compositions and methods of use thereof
WO2023080939A1 (fr) 2021-11-03 2023-05-11 Epitracker, Inc. Pentadécanoylcarnitine pour le traitement d'affections liées à la qualité du vieillissement et à la longévité
CN119300802A (zh) 2022-03-31 2025-01-10 高德美控股有限公司 用于敏感皮肤的个人护理组合物和其使用方法
WO2025019570A1 (fr) * 2023-07-18 2025-01-23 Sytheon Ltd. Nouveaux sels à base d'acides aminés, compositions et procédés pour traiter la peau et rajeunir la peau et prolonger la longévité

Family Cites Families (88)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1792346C3 (de) * 1968-08-22 1980-10-23 Rotta Research Laboratorium S.P.A., San Fruttuoso Di Monza, Mailand (Italien) Pharmazeutisches Präparat für die Behandlung von degenerativen Gelenkerkrankungen
US3856934A (en) * 1970-06-24 1974-12-24 A Kligman Skin depigmentation
US4016287A (en) * 1972-07-17 1977-04-05 Boehringer Ingelheim Gmbh Dermatological compositions containing an acylamino-carboxylic acid or an alkyl ester thereof
US4165385A (en) * 1973-05-29 1979-08-21 Dianis Creations, Inc. Water-in-oil emulsion for skin moisturizing
DE2330927C2 (de) * 1973-06-18 1983-11-10 Ideal-Standard Gmbh, 5300 Bonn Aus Kunststoff gebildetes sanitäres Wasserventil
FR2244541A1 (en) * 1973-08-01 1975-04-18 Fabre Sa Pierre Amino acid salts of quinine alkaloids - as phospho-lipase inhibitors and anti-acne agents
US3932622A (en) * 1974-01-11 1976-01-13 General Foods Corporation Skin moisturizer
AR207237A1 (es) * 1974-02-25 1976-09-22 Thomas A Procedimiento para obtener extractos biologicos estables liofilizados solubles constituidos por complejos proteicos termorresistentes
JPS6039042B2 (ja) * 1976-04-10 1985-09-04 田辺製薬株式会社 パ−マネントウエ−ブ用第１液
US4176197A (en) * 1978-02-03 1979-11-27 Dominion Pharmacal, Inc. Method for treating acne vulgaris
CA1156028A (fr) 1979-11-09 1983-11-01 Wolfgang K. F. Otto Appareil et procede pour la finition de surface des tissus
JPS5679618A (en) * 1979-11-30 1981-06-30 Tanabe Seiyaku Co Ltd Liquid for permanent wave
JPS56155298A (en) * 1980-05-02 1981-12-01 Tanabe Seiyaku Co Shampoo composition
JPS57131712A (en) * 1980-12-24 1982-08-14 Warner Lambert Co Caries controlling method and composition
US4603146A (en) 1984-05-16 1986-07-29 Kligman Albert M Methods for retarding the effects of aging of the skin
JPS5913708A (ja) * 1982-07-14 1984-01-24 Shiseido Co Ltd 化粧料
DE3435842A1 (de) * 1984-09-29 1986-04-10 Wella Ag Verwendung von n-(alpha)-acetyl-lysin-amid in hautbehandlungsmitteln zur verstaerkten braeunung der haut
FR2572399B1 (fr) 1984-10-31 1987-01-16 Panmedica Sa Nouveaux derives de l'adamantanamine, leurs procedes de preparation et medicaments les contenant
JPH0645524B2 (ja) * 1985-03-13 1994-06-15 岩瀬コスファ株式会社 皮膚外用剤
US4748022A (en) * 1985-03-25 1988-05-31 Busciglio John A Topical composition
IT1183530B (it) * 1985-03-29 1987-10-22 Monteluos S P A Composizioni per cosmesi comprendente perfluoropolieteri
US4762822A (en) * 1985-08-08 1988-08-09 Ettinger Anna C Reduction of gastrointestinal disease-producing organisms with sialic acid and gangliosides
GB2180153A (en) * 1985-09-10 1987-03-25 Rory Ltd Compositions containing acetylcysteine
US4827016A (en) * 1985-09-16 1989-05-02 Morgan Lee R Method and compounds for reducing dermal inflammations
US4708965A (en) * 1985-09-16 1987-11-24 Morgan Lee R Method of treating herpes virus infections with N,N'-diacetylcystine and derivatives
US4772591A (en) * 1985-09-25 1988-09-20 Peritain, Ltd. Method for accelerated wound healing
GB8524807D0 (en) * 1985-10-08 1985-11-13 Hendry N G C Tissue growth regulation
DE3602670A1 (de) * 1986-01-29 1987-07-30 Speck Ulrich Verwendung von n-acetylglucosamin zur therapie degenerativer gelenkprozesse und verwandter erkrankungen
US5300494A (en) * 1986-06-06 1994-04-05 Union Carbide Chemicals & Plastics Technology Corporation Delivery systems for quaternary and related compounds
US5547988B1 (en) 1986-12-23 1997-07-15 Tristrata Inc Alleviating signs of dermatological aging with glycolic acid lactic acid or citric acid
US5091171B2 (en) 1986-12-23 1997-07-15 Tristrata Inc Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use
US5385938B1 (en) 1986-12-23 1997-07-15 Tristrata Inc Method of using glycolic acid for treating wrinkles
AU618517B2 (en) 1986-12-23 1992-01-02 Eugene J. Van Scott Additives enhancing topical actions of therapeutic agents
US5389677B1 (en) 1986-12-23 1997-07-15 Tristrata Inc Method of treating wrinkles using glycalic acid
NZ223558A (en) * 1987-02-18 1990-04-26 Milor Scient Ltd Acne treatment composition
US5641475A (en) 1987-05-15 1997-06-24 Tristrata, Inc. Antiodor, antimicrobial and preservative compositions and methods of using same
US5258391A (en) 1987-05-15 1993-11-02 Scott Eugene J Van Phenyl alpha acyloxyalkanoic acids, derivatives and their therapeutic use
US5643949A (en) 1987-05-15 1997-07-01 Tristrata, Inc. Phenyl alpha acyloxyalkanoic acids, derivatives and their therapeutic use
EP0293837B1 (fr) * 1987-06-01 1992-01-15 Keikichi Sugiyama Composition applicable sur la chevelure ou le scalp
FR2619711B1 (fr) * 1987-09-02 1991-01-11 Givaudan La Virotte Cie Ets Application cosmetique de derives de la proline, de l'hydroxyproline et/ou du melange d'acides amines resultant de l'hydrolyse du collagene
JP2557240B2 (ja) * 1987-12-21 1996-11-27 雪印乳業株式会社 皮膚老化予防剤
AU2971689A (en) * 1988-02-11 1989-08-17 Estee Lauder Inc. Tanning compositions and their use
FR2609397B1 (fr) 1988-02-23 1991-12-13 Serobiologiques Lab Sa Utilisation d'une substance ou composition de nature glucidique comme principe actif d'une composition dermatologique et/ou cosmetologique et/ou pharmaceutique et/ou stimulante cellulaire, et composition contenant une telle substance ou composition de nature glucidique
GB8918709D0 (en) * 1989-08-16 1989-09-27 Unilever Plc Cosmetic composition
US5470567A (en) * 1989-08-24 1995-11-28 Bristol Myers Squibb Company Synergistic skin depigmentation composition
JP2886591B2 (ja) * 1990-01-27 1999-04-26 協和醗酵工業株式会社 化粧料
IL97012A0 (en) * 1990-01-30 1992-03-29 Gist Brocades Nv Topical preparations for treating human nails
JPH0578243A (ja) * 1990-12-11 1993-03-30 Shiseido Co Ltd 鎮痒剤及び鎮痒組成物
EP0514576A1 (fr) * 1991-05-24 1992-11-25 Societe Des Produits Nestle S.A. Mélange antioxydant liposoluble
US5296500A (en) * 1991-08-30 1994-03-22 The Procter & Gamble Company Use of N-acetyl-cysteine and derivatives for regulating skin wrinkles and/or skin atrophy
GB9118866D0 (en) * 1991-09-04 1991-10-23 Unilever Plc Cosmetic composition
FR2688136B1 (fr) * 1992-03-03 1995-06-09 Oreal Composition cosmetique contenant des pigments melaniques en association avec certains tocopherols, et procede de protection de la peau, des cheveux, des muqueuses et des compositions cosmetiques.
AU2771792A (en) * 1992-03-31 1993-11-08 Kyowa Hakko Kogyo Co. Ltd. Novel cosmetic
EP0639068A1 (fr) * 1992-05-05 1995-02-22 The Procter & Gamble Company Composition de traitement de l'acne
US5286480A (en) 1992-06-29 1994-02-15 The Procter & Gamble Company Use of N-acetylated amino acid complexes in oral care compositions
US5677285A (en) * 1992-08-03 1997-10-14 Fidia S.P.A. Derivatives of neuraminic acid
DE4228455A1 (de) 1992-08-26 1994-09-15 Beiersdorf Ag Kosmetische und dermatologische Lichtschutzformulierungen mit einem Gehalt an Thiolen und/oder Thiolderivaten
CN1045589C (zh) * 1992-12-09 1999-10-13 协和发酵工业株式会社 N-酰基谷氨酰胺衍生物
DE69310339T2 (de) * 1993-02-19 1997-08-21 Philippe Djian Präparate, die Corneozyt Proteine enthalten
JPH11501611A (ja) 1993-06-18 1999-02-09 アークチュラス、ファーマシューティカル、コーポレーション 過角化及びプロテアーゼによって媒介される疾患の治療のための方法
FR2714597B1 (fr) * 1993-12-30 1996-02-09 Oreal Composition hydratante pour le traitement simultané des couches superficielles et profondes de la peau, son utilisation.
FR2715565B1 (fr) * 1994-01-31 1996-03-15 Oreal Composition cosmétique ou dermatologique stabilisée contenant plusieurs précurseurs d'un même actif pour maximaliser sa libération, son utilisation.
US5468476A (en) * 1994-03-16 1995-11-21 Ahluwalia; Gurpreet S. Reduction of hair growth
US5451405A (en) * 1994-04-25 1995-09-19 Chesebrough-Pond's Usa Co. Skin treatment composition
WO1996000561A1 (fr) * 1994-06-30 1996-01-11 Kyowa Hakko Kogyo Co., Ltd. Produit stimulant la pousse des cheveux
JP3760287B2 (ja) * 1994-11-24 2006-03-29 株式会社コーセー 化粧料
US5472698A (en) * 1994-12-20 1995-12-05 Elizabeth Arden Co., Division Of Conopco, Inc. Composition for enhancing lipid production in skin
JP3485375B2 (ja) * 1995-02-17 2004-01-13 株式会社資生堂 皮膚外用剤
US5866142A (en) * 1995-07-20 1999-02-02 Riordan; Neil H. Skin treatment system
US5776920A (en) * 1995-08-02 1998-07-07 Quarles; Ruth Method for treatment of psoriasis
FR2739556B1 (fr) 1995-10-04 1998-01-09 Oreal Utilisation de carbohydrates pour favoriser la desquamation de la peau
US5733535A (en) * 1995-10-25 1998-03-31 The Procter & Gamble Co. Topical compositions containing N-acetylcysteine and odor masking materials
US5939082A (en) * 1995-11-06 1999-08-17 The Procter & Gamble Company Methods of regulating skin appearance with vitamin B3 compound
US5652273A (en) * 1995-11-30 1997-07-29 Henry; James Reduction of hair growth
JPH09255526A (ja) * 1996-03-27 1997-09-30 Shiseido Co Ltd 老化防止化粧料
GB9606429D0 (en) * 1996-03-27 1996-06-05 Boots Co Plc Pharmaceutical compositions
US5728371A (en) * 1996-04-29 1998-03-17 L'oreal, S.A. Skin protection, fragrance enhancing and vitamin delivery composition
JPH09323915A (ja) * 1996-06-05 1997-12-16 Ichimaru Pharcos Co Ltd Ｎ−アセチルチロシン誘導体を有効成分とするメラニン生成抑制剤、および皮膚外用剤又は浴用剤への応用
US5993787A (en) * 1996-09-13 1999-11-30 Johnson & Johnson Consumer Products, Inc. Composition base for topical therapeutic and cosmetic preparations
CN1161198A (zh) * 1996-10-29 1997-10-08 贾增申 消除皮肤皱纹及疤痕的外用膏剂
JPH10163110A (ja) * 1996-11-27 1998-06-19 Kyocera Corp 半導体装置
IT1288257B1 (it) * 1996-11-29 1998-09-11 Paoli Ambrosi Gianfranco De Composizione per uso cosmetico,farmaceutico o dietetico a base di un aminozucchero e/o di un acido poliidrossilico
CN1067246C (zh) 1996-12-27 2001-06-20 中国人民解放军第三军医大学 N－乙酰－d－氨基葡萄糖在制备治疗皮肤癣菌的药物中的应用
US5804594A (en) * 1997-01-22 1998-09-08 Murad; Howard Pharmaceutical compositions and methods for improving wrinkles and other skin conditions
ATE271873T1 (de) * 1997-05-21 2004-08-15 Bio Minerals Nv Verwendung von glukosamin und glukosaminderivaten zur schnellen linderung von juckreiz oder lokalisiertem schmerz
US6149924A (en) * 1998-07-20 2000-11-21 Biomed Research & Technologies, Inc. Composition for enhancing lipid production, barrier function, hydrogen peroxide neutralization, and moisturization of the skin
US6159485A (en) 1999-01-08 2000-12-12 Yugenic Limited Partnership N-acetyl aldosamines, n-acetylamino acids and related n-acetyl compounds and their topical use
US9616534B2 (en) 2013-11-25 2017-04-11 Invent-A-Part Modular structures for motion stages

Also Published As

Publication number Publication date
EP1570840A3 (fr) 2005-11-16
JP2002534369A (ja) 2002-10-15
EP2311452B2 (fr) 2020-12-30
EP2080504A2 (fr) 2009-07-22
CA2358457A1 (fr) 2000-07-13
ES2248042T3 (es) 2006-03-16
USRE44302E1 (en) 2013-06-18
BR0007430A (pt) 2001-10-16
ES2477556T3 (es) 2014-07-17
EP2311452B1 (fr) 2014-04-02
HK1156853A1 (en) 2012-06-22
ES2325160T3 (es) 2009-08-27
US6524593B1 (en) 2003-02-25
AU775209B2 (en) 2004-07-22
DE60022162T3 (de) 2011-09-29
USRE41278E1 (en) 2010-04-27
CA2778317A1 (fr) 2000-07-13
EP1639994A2 (fr) 2006-03-29
MXPA01006917A (es) 2003-06-04
WO2000040217A1 (fr) 2000-07-13
AU2408000A (en) 2000-07-24
DE60022162T2 (de) 2006-03-23
CA2778317C (fr) 2014-09-16
EP1143925B1 (fr) 2005-08-24
EP1143925A1 (fr) 2001-10-17
CA2683980A1 (fr) 2000-07-13
USRE42902E1 (en) 2011-11-08
EP1570840A2 (fr) 2005-09-07
EP1143925B2 (fr) 2011-01-26
EP2311452B9 (fr) 2014-12-24
EP2311452A1 (fr) 2011-04-20
DE60022162D1 (de) 2005-09-29
CA2358457C (fr) 2010-03-23
CA2683980C (fr) 2012-08-07
ES2248042T5 (es) 2011-06-03
US6159485A (en) 2000-12-12
EP1570840B1 (fr) 2009-04-01
USRE44017E1 (en) 2013-02-19
USRE41339E1 (en) 2010-05-18
DE60041934D1 (de) 2009-05-14
JP2012072172A (ja) 2012-04-12
CN1336817A (zh) 2002-02-20

Similar Documents

Publication Publication Date Title
WO2000040217B1 (fr) Composition topique comprenant des aldosamines de n-acetyle ou des acides amines de n-acetyle
EP0599819B1 (fr) Utilisation d'acides hydroxycarboxyliques et leurs dérivés pour la préparation de compositions dermatologiques topiques pour le traitement de rides
US5889054A (en) Method of using beta hydroxy acids for treating wrinkles
US6824786B2 (en) Compositions comprising phenyl-glycine derivatives
US20030229141A1 (en) N-acetyl cysteine and its topical use
WO2003086291A2 (fr) Compositions d'uree
EP1009398A1 (fr) Complexes moleculaires et liberation progressive d'alpha-hydroxyacides
US20040147452A1 (en) Non-amphoteric glutathione derivative compositions for tropical application
HK1089365A (en) Topical composition comprising n-acetylaldosamines or n-acetylamino acids

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 00802605.X

Country of ref document: CN

AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: B1

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: B1

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

B Later publication of amended claims
WWE Wipo information: entry into national phase

Ref document number: 24080/00

Country of ref document: AU

ENP Entry into the national phase

Ref document number: 2358457

Country of ref document: CA

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 2000 591974

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: PA/a/2001/006917

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 2000902347

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2000902347

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

ENP Entry into the national phase

Ref document number: 2358457

Country of ref document: CA

WWG Wipo information: grant in national office

Ref document number: 24080/00

Country of ref document: AU

WWG Wipo information: grant in national office

Ref document number: 2000902347

Country of ref document: EP

DPE2 Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101)